Gerogetown University Lombardi Cancer Center — Washington D.C., District of Columbia

Gerogetown University Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20057.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Gerogetown University Lombardi Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gerogetown University Lombardi Cancer Center?

Gerogetown University Lombardi Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gerogetown University Lombardi Cancer Center conducted?

Gerogetown University Lombardi Cancer Center has 1 clinical trials on record. Their work covers Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors.

Is Gerogetown University Lombardi Cancer Center accredited by Crixeo Health?

Gerogetown University Lombardi Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gerogetown University Lombardi Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.